Voya Investment Management LLC boosted its stake in AngioDynamics, Inc. (NASDAQ:ANGO) by 222.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 43,654 shares of the medical instruments supplier’s stock after buying an additional 30,127 shares during the period. Voya Investment Management LLC owned 0.12% of AngioDynamics worth $708,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. State of Alaska Department of Revenue increased its stake in shares of AngioDynamics by 91.7% during the second quarter. State of Alaska Department of Revenue now owns 6,768 shares of the medical instruments supplier’s stock valued at $109,000 after purchasing an additional 3,238 shares in the last quarter. Teachers Retirement System of The State of Kentucky increased its stake in shares of AngioDynamics by 77.5% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock valued at $123,000 after purchasing an additional 3,100 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of AngioDynamics by 3.0% during the first quarter. Municipal Employees Retirement System of Michigan now owns 7,200 shares of the medical instruments supplier’s stock valued at $125,000 after purchasing an additional 210 shares in the last quarter. Acrospire Investment Management LLC increased its stake in shares of AngioDynamics by 3.7% during the second quarter. Acrospire Investment Management LLC now owns 8,915 shares of the medical instruments supplier’s stock valued at $145,000 after purchasing an additional 317 shares in the last quarter. Finally, BlueCrest Capital Management Ltd bought a new position in shares of AngioDynamics during the first quarter valued at approximately $175,000. Institutional investors and hedge funds own 95.67% of the company’s stock.

ANGO has been the subject of a number of analyst reports. Canaccord Genuity reaffirmed a “hold” rating and set a $17.00 target price on shares of AngioDynamics in a research note on Tuesday, July 18th. Barclays PLC decreased their target price on shares of AngioDynamics from $17.00 to $16.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 19th. Zacks Investment Research downgraded shares of AngioDynamics from a “hold” rating to a “sell” rating in a research note on Thursday, July 20th. BidaskClub downgraded shares of AngioDynamics from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Finally, KeyCorp reaffirmed a “hold” rating on shares of AngioDynamics in a research note on Friday, August 25th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $18.60.

AngioDynamics (NASDAQ:ANGO) last posted its earnings results on Thursday, September 28th. The medical instruments supplier reported $0.12 EPS for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.04). AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The firm had revenue of $85.40 million for the quarter, compared to analysts’ expectations of $86.12 million. During the same period in the previous year, the company earned $0.17 EPS. The company’s revenue was down 3.1% on a year-over-year basis.

TRADEMARK VIOLATION NOTICE: This piece of content was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was stolen and reposted in violation of United States & international copyright and trademark laws. The correct version of this piece of content can be read at https://www.thecerbatgem.com/2017/11/02/angiodynamics-inc-ango-shares-bought-by-voya-investment-management-llc.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Stock Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related stocks with our FREE daily email newsletter.